Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as ...

SINGAPORE] Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding ...

By Yantoultra Ngui SINGAPORE (Reuters) -At least five companies from mainland China or Hong Kong are planning IPOs, dual ...

Turion Labs, a new biotech platform formed by South Korea’s S&S LAB and Indonesia’s Future Lestari, has launched operations ...

A Singapore-based startup raised a $45 million Series B to start testing a gene therapy in humans next year for a genetic ...

A new venture in Singapore aims to tackle two of the biggest challenges faced by biotech and food tech start-ups in South ...

SINGAPORE: Biotechnology firm Mirxes had over 100 employees in 2021. But in just three years, the company has more than doubled in size, with over 300 staff globally today. The Singapore ...

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, four sources said, as Chinese firms look to ...

First Patient dosed in Phase I/IIa Basket Trial for Solid Tumours at Mater Hospital, North SydneyRecruitment to open this ...

At least five Chinese and HK firms eye listings on SGX. Read more at straitstimes.com. Read more at straitstimes.com.